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Abstract
A scalable four-step synthesis of the ornithine transcarbamylase inhibitor N5-phosphonoacetyl-l-ornithine (PALO) is achieved
through boroxazolidinone protection of ornithine. Investigations in the model organism Saccharomyces cerevisiae found that, in
contrast to a previous report, PALO did not influence growth rate or expression of genes involved in arginine metabolism.
Keywords: PALO, Ornithine transcarbamylase, Saccharomyces cerevisiae, Arginine biosynthesis
N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate
transition-state analog which competitively inhibits ornithine
transcarbamylase (OTC) in vitro, blocking biosynthesis of citrulline in both the urea and the arginine biosynthetic pathways (Figure 1). 1, 2 Competitive inhibitors of amino acid metabolism have been key components in studies ranging from
arginine starvation in fungi and bacteria to studies on OTC deficiency. 3, 4
PALO has been tested as a potential tool for in vivo metabolic studies. It failed to inhibit citrulline biosynthesis in isolated rat mitochondria or intact rat hapatocytes,5 and did not
inhibit growth of the bacterium Escherichia coli.6 These failures
were attributed to the inability of PALO to cross cell membranes. In contrast, Kinney and Lusty showed that PALO induced arginine limitation in the yeast Saccharomyces cerevisiae.4
The regulation of arginine metabolism in fungi is particularly
important to understand because of the role of this amino acid
in protein synthesis, as a nitrogen source and in signaling. 2,
7–10 We now report a short and scalable synthesis of PALO, as
well as results of investigations into the influence of PALO on
growth and arginine metabolism in S. cerevisiae.
The first syntheses of PALO employed the direct functionalization of copper-complexed ornithine. This strategy,
while rapid, requires a significant set of purification steps. 1, 2,
5, 11 Several more traditional routes begin with partially protected derivatives of ornithine, 3, 5 some of which are no longer commercially available. As illustrated in Scheme 1, we
found that temporary masking of the amino acid of ornithine
2351

as the boroxazolidinone derivative enables a rapid and scalable synthesis of PALO in highly pure form. Reaction of lornithine with 9-borabicyclononane (9-BBN) furnished the
corresponding boroxazolidinone, 12, 13 which was directly condensed with dibenzylphosphonoacetic acid (2) to furnish amide 3.14 We were unable to achieve deprotection of the boroxazolidinone with aq HCl or methanolic ethylenediamine,12 even
though these conditions were successfully modeled on the corresponding adduct of phenylalanine.15 Fortunately, dissolution of 3 in MeOH/CHCl3 resulted in slow but clean deprotection to amino acid 4.16 Hydrogenolysis of the benzyl esters
proceeded nearly quantitatively to furnish PALO (1) as a neutral molecule which was pure by 1H, 13C, and 31P NMR. The
PALO·NH4 salt could be prepared by elution from an ion-exchange column.

Figure 1. PALO; OTC-catalyzed synthesis of citrulline.
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Scheme 1. Synthesis of PALO (1).

Kinney and Lusty reported that PALO increased expression of CPA1, CPA2, HIS3, and TRP5 reporter constructs in the
yeast S. cerevisiae.4 The data were consistent with limitation of
arginine leading to specific up regulation of arginine biosynthetic genes (CPA1 and CPA2), and a general amino acid starvation response typified by up regulation of HIS3 and TRP5.
We tested whether treatment with PALO resulted in
changes in mRNA accumulation and/or translation of genes
involved in amino acid biosynthesis. We examined expression of two genes required for arginine biosynthesis; ARG5,6,
which encodes a protein involved in the second and third
steps of arginine biosynthesis from glutamate, and CPA1,
which encodes a subunit of arginine-specific carbamyl-phosphate synthetase. Both of these genes are up regulated specifically in response to arginine limitation. Expression of TRP5,
which encodes an enzyme that catalyzes the final step in tryptophan biosynthesis, was also examined as an indicator of the
general amino acid starvation response. Quantitative northern analysis was performed to measure mRNA abundance, a
measure of the combined rates of transcription and mRNA decay. Western analysis was used to look at the level of protein
synthesis for these genes. This combined approach enabled direct evaluation of effects on transcription, mRNA stability, and
translation.
Although the yeast strains from the earlier studies were
not available,4 they were derived from the W303 genetic background, which usually carry the can1-100 mutation.17 As
CAN1 encodes an arginine permease required for efficient uptake of arginine, the can1-100 mutation is not well suited for
the current experiments. As a compromise, and to assess if
PALO will be generally useful as a metabolic tool in S. cerevisiae, the current data was obtained using the BY4741 strain
of S. cerevisiae.18 This strain is derived from S288C, the strain
used in the systematic sequencing project, and it is the most
commonly used genetic background for genome-wide functional analyses.
If PALO affects transcription or mRNA stability, we expected to observe an increase in expression of ARG5,6, CPA1,
and TRP5 mRNA transcripts in the presence of PALO. We also
expected that addition of arginine would relieve the arginine
limitation induced by PALO. Cells were grown and treated
with either 15 μM of the synthesized PALO, 1 mg/mL l-arginine, or 15 μM of the synthesized PALO and 1 mg/mL l-arginine as described by Kinney and Lusty.4 An untreated culture
was grown in the same media as a control. The abundance of
ARG5,6, CPA1, and TRP5 mRNAs was measured by quantitative northern analysis (Figure 2A). The abundance of ARG5,6,
CPA1, and TRP5 mRNAs in the PALO treated cells was not

Figure 2. PALO has no effect on expression of the ARG5,6, CPA1, and
TRP5 genes in Saccharomyces cerevisiae. S. cerevisiae strains 18, 19 were
inoculated from a saturated culture into minimal medium supplemented with leucine, methionine, uracil and histidine. Cultures were
treated with 15 μM PALO in a potassium phosphate pH 6.8 buffer, potassium phosphate buffer pH 6.8 alone (untreated), 1 mg/mL l-arginine, or both 15 μM PALO and 1 mg/mL l-arginine at the time of inoculation. Cells were incubated at 30 °C and then harvested at mid-log
growth phase (OD600 0.4–0.6). (A) Northern blots were prepared with
total RNA extracted from BY4741 18, 19 and probed with oligolabeled
DNA probes.20 DNA probes were generated using primer sets for amplifying yeast open reading frames based on the sequences available
from the Saccharomyces Genome Database. Shown are representative
phosphorimages of a northern blot probed with radioactive ARG5,6,
CPA1, TRP5, and SCR1 DNAs. SCR1 was used as a loading control.
Quantitative results depicted are the average of three replicate trials
and are normalized to the SCR1 loading control. (B) Western blots were
prepared using protein extracts from S. cerevisiae YSC1178-7500224,
YSC1178-7502950 and YSC1178-7500415 strains19 expressing TAP-fusion proteins Arg5,6-TAP, Cpa1-TAP, and Trp5-TAP, respectively, as
well as BY4741 (untagged control). 21, 22 The TAP-tagged proteins were
detected using an anti-TAP antibody. No proteins bound the anti-TAP
antibody in the untagged control. Duplicate polyacrylamide gels were
stained with Coomassie blue for use as loading controls. The corresponding loading controls are shown beneath the western blots.

significantly different from the untreated cells. The abundance of ARG5,6 and CPA1, but not TRP5 mRNAs was lower
in cells treated with arginine regardless of whether the cells
were treated with PALO or not. Additionally, the abundance
of the TRP5 transcript did not show any variation in response
to addition of PALO, arginine or both. In summary treatment
with PALO had no effect on the abundance of ARG5,6, CPA1
or TRP5 mRNAs.
The possible effect of PALO on translation was investigated by western analysis (Figure 2B). If PALO affects translation, we expected to see an increase in the production of
Arg5,6p, Cpa1p, and Trp5p in the presence of PALO. We also
expected that addition of l-arginine would reduce protein levels of Arg5,6p and Cpa1p, but not Trp5p. We used cell extracts from strains (YSC1178-7500224, YSC1178-7502950 and
YSC1178-7500415, respectively) carrying TAP-tagged alleles
of ARG5,6, CPA1 and TRP5 for the western analysis. These
strains produce a TAP-fusion protein for each gene which can
be detected on western blots with anti-TAP antibodies. BY4741
was used as an untagged control because it is the parent strain
for the TAP-tagged strains. Cells were grown and treated in
the same manner as for the northern analysis. Measurement of
the signal intensity of the bands detected by western blotting
revealed no difference in the production of Arg5,6p, Cpa1p, or
Trp5p between strains treated with 15 μM PALO and the con-
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trol. As expected, addition of l-arginine reduced production of
Arg5,6p and Cpa1p, but not of Trp5p regardless of whether
PALO was added or not. In summary, PALO had no effect on
Arg5,6p, Cpa1p, and Trp5p protein levels.
PALO did not affect the growth rate of BY4741 in minimal
media or nitrogen-limiting medium (data not shown), used in
an attempt to increase sensitivity to PALO by lowering intracellular arginine concentrations. Growth in nitrogen-limiting
medium induces cells to use amino acids, including arginine,
as a source of nitrogen. These findings were consistent with
the observations reported by Kinney and Lusty.4
In conclusion, we have developed an efficient synthesis of
very pure PALO by a route suitable for both analytical and
preparative applications. In contrast to a previous report describing PALO-induced arginine starvation,4 we observed no
response in S. cerevisiae strain BY4741 to treatment with PALO
(Figure 2). The discrepancy suggests either that not all yeast
strains are sensitive to PALO or that the earlier indications of
arginine starvation resulted from impurities in the samples of
PALO employed. The current results are consistent with observations that PALO had no effect in isolated rat mitochondria, intact rat hepatocytes or E. coli. 5, 6
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General Experimental Conditions: Reagents and solvents were used as supplied commercially, except THF,
which was distilled from Na/Ph2CO, and methanol, which was distilled from Mg/I2. 1H, 13C, and 31P spectra
were recorded in CDCl3 at 400, 100, and 121.5 MHz, respectively, unless noted. TLC was monitored via one or
more of the following: UV; vanillin (charring); ninhydrin; bromocresol green.1 Mass spectra were obtained at
the Nebraska Center for Mass Spectrometry.
Synthesis of PALO:
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L-ornithine, 9-borabicyclononyl coordination compound was prepared using a reported procedure,2 except
that L-ornithine•HCl (4.22 g, 25 mmol) was added before the reaction was brought to reflux. The crude product
was often obtained as a viscous yellow-brown oil rather than the reported gummy solid. Washing of the crude
product with ether, followed by drying under high vacuum, furnished a white powder (5.82 g, 92 %) which was
used without further purification. HRMS m/z calcd. for C13H26BN2O2 (M+): 253.20873; found: 253.20774 (3.9
ppm); [α]: -5.2° (c 2.0, MeOH).
Dibenzylphosphonoacetic acid (2) was prepared in two steps.3 Alkylation of dibenzylphosphite (5.23 g, 20
mmol) with MeI furnished dibenzyl methyl phosphonate (3.83 g, 69%).The residue obtained from filtration and
concentration was purified by flash chromatography (Rf = 0.34, 1:1 EA/hex). Spectra were identical to the
previous report,3 with the following exceptions: 1H signals reported at 4.90-5.2 were resolved as 5.08 and 4.98
(dd, each 2H, J = 8.3-8.9 and 11.8 Hz, 3JH-P coupling); 13C NMR, 136.4 (d, 3JCP = 6.1 Hz), 128.6, 128.4, 127.9,
67.1 (d, 2JCP = 6.2 Hz), and 11.7 (d, 1JCP = 144 Hz); 31P 31.7; HRMS m/z calcd. for C15H17O3P (M+H) +:
277.099358; found 277.10021 (3.1 ppm).
In the second step,3 carboxylation of the phosphonate (2.76 g, 10 mmol) with CO2-saturated ether furnished 2
(1.85 g, 58%), which was sufficiently pure to be used directly. A sample was purified by chromatography in
EA/hex (Rf = 0.70, EA). Spectral data were identical to those previously reported,3 with the following
exceptions or additions: the 1H multiplet reported at 5.08 ppm was resolved into two dd [5.12 and 5.08, each dd,
2H, 9.1, 17.3 Hz, with the latter due to 3JHP coupling); 13C NMR 167.8 (d, 3JCP = 5.3 Hz) 135.7, 128.6, 128.1,
68.6 (d, JCP = 6.3 Hz), 34.5 (d, 1JCP = 136 Hz); 31P NMR 22.2; IR (film) v 3200-2500, 1720, 1210, 990, 730,
695 cm-1; HRMS m/z calcd. for C16H21O3P (M+H)+: 321.08919; found: 321.08806 (3.5 ppm).
N5-([2-Dibenzyloxyphosphinyl)acetyl])-L-ornithine, 9-borabicyclononane adduct (3): In an N2-flushed,
oven-dried, 50 mL round bottom flask was added dry THF (33 mL) and 9-BBN-protected L-ornithine (1.31 g,
5.2 mmol). The mixture was stirred until homogeneous whereupon 2 (1.50 g, 4.7 mmol), dimethyl
aminopyridine (0.574 g, 4.7 mmol), and dicyclocarbodiimide (1.07 g, 5.2 mmol) were added. The reaction was
stirred overnight at rt, resulting in a suspension. The residue obtained upon concentration was re-suspended in
ethyl acetate and filtered. The filtrate was sequentially washed with sat. aq. NaHCO3 (2 x 15 mL), water (15
mL), 1 M HCl (2 x 15 mL), and water (15 mL). The organic layer was dried with anhydrous Na2SO4 and
filtered. The residue obtained upon concentration was purified by flash chromatography (Rf = 0.40, 1%
MeOH/EA) to yield 3 as a white solid (1.61 g, 2.9 mmol, 62%); 1H NMR 7.30 – 7.38 (m, 10H), 6.78 (t, 1H, J =
5.7 Hz), 5.31 (dd, 1H, J = 8.0 Hz, J = 11.6 Hz), 4.92-5.06 (m, 5H), 3.62-3.69 (m, 1H), 3.34-3.43 (m, 1H), 3.083.16 (m, 1H), 2.86 (d, 2H, J = 21.0 Hz), 1.41-2.10 (m, 16H), and 0.59 (d, 2H, J = 12.0 Hz); 13C NMR 174.4,
135.5, 128.8, 128.0, 68.3, 54.9, 38.9, 31.4, 28.0, 24.1; 31P NMR (75.5 MHz) 23.3; IR (solid) v 3292, 3174, 3108,
2923, 2877, 2838, 1692, 1664, 1240, 1214, 1008, 998, 724 cm-1; HRMS m/z calcd. for C29H40BN2O6P (M+):
555.27953; found: 555.27801 (2.7 ppm); [α]: -13.4° (c 2.0, CHCl3); MP = 125-129° C.
N5-([2- Dibenzyloxyphosphinyl)acetyl])-L-ornithine (4): Into a ~25 mL vial was added 3 (120 mg, 0.22
mmol), methanol (200 µL), and CHCl3 (10 mL).4 The reaction was stirred at rt for 72 hours and monitored by
TLC (Rf = 0.50 on C18 RP-TLC plates in 3:1 MeOH/H2O, developed with ninhydrin). Once the reaction
appeared to be complete, the solution was concentrated to an oil, purified by ion exchange (~2 g Dowex 50X2200; column – 1.5 cm x 30 cm, pre-acidified with 2M HCl, eluting solvent: 1% NH4OH), and lyophilized to

2

yield 4 as a fluffy, white solid (85.6 mg, 0.20 mmol, 90%). 1H NMR (MeOH) 7.39-7.32 (m, 10H), 5.09 (dd, 2H,
J = 11.8, 11.4 Hz; ABX w/5.04 ppm), 5.04 (dd, 2H, J = 11.8, 11.4 Hz; ABX w/ 5.09 ppm), 3.53 (dd, 1H, J =
6.6, 6.6 Hz), 3.27-3.14 (m, 2H), 3.02 (d, 2H, J = 21.7 Hz), 1.93-1.75 (m, 2H), and 1.66-1.57 (m, 2H); 13C NMR
(MeOD) 174.4, 137.7, 129.8, 129.8, 129.3, 69.7, 55.9, 40.4, 37.0, 35.5, 29.9, and 26.3; 31P NMR (162 MHz,
MeOD) 24.1; IR (solid) 3350-3250, 3150-2800, 1630, 1550, 1230, 995, 900, 825, and 670 cm-1; HRMS m/z
calcd. for C21H28N2O6P (M+H)+: 435.16850; found: 435.16846 (0.1 ppm); [α]: +1.2° (c 2.1, MeOH); MP = 167170°C.
N5-(2-Phosphonoacetyl)- L-ornithine (PALO, 1): Phosphonate 4 (133 mg, 0.3 mmol was mixed with formic
acid (1.1 mL) and 10% Pd/C (54 mg, 28 mol %) in a N2-flushed vial. The vial was capped with a rubber septum
and the mixture stirred for 5 min while being flushed with nitrogen. The mixture was then placed under an atm
of H2 (balloon) and the headspace briefly vented (needle) to purge N2. The reaction was stirred for 24 h and then
filtered through a plug of Celite. The filtrate was lyophilized, yielding a white solid (72 mg, 95 %) that
deformed at ~ 70 °C. 1H NMR (300 MHz, D2O) 4.00 (t, 1H, J = 5.9 Hz), 3.26 (t, 2H, J = 5.9 Hz), 2.75 (d, 2H,
2
JH-P = 20.4 Hz), 2.08 (m, 2H), 1.54 (m, 2H) ; 13C NMR (75.5 MHz, D2O) 172.69, 170.22, 53.10, 38.67, 38.42
(d, J = 122 Hz), 27.24, and 24.10; 31P NMR (121.5 MHz, D2O) 15.0; IR (solid) v 3600-2350, 1715, 1630, 1547,
1300, 1204, 1020, and 915; HRMS m/z calcd. for C6H13N2O6P (M+H)+: 255.074600; found: 255.074685 (0.3
ppm); [α]: +3.6° (c 1.0, H2O).

1.
2.
3.
4.

Handbook of Thin-Layer Chromatography (Chromatographic Science, Vol. 89), Sherma, J.; Fried, B.,
Eds., Marcel Dekker, New York, 2003.
Fields, S. C.; Dent III, W. H.; Erickson, R. Parker, M. H., Tromiczak, E. G. Org. Lett. 2002, 4, 1249.
Koppel, G. A.; Kinnick, M. D. Tetrahedron Lett. 1974, 9, 711-13; Grison, C., Coutrot, P., Comoy, C.,
Balas, L., Joliez, S., Lavecchia, G., Oliger, P., Penverne, B., Serre, V., Herve, G. Eur. J. Med. Chem.
2004, 39, 333.
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